Global Wearable ECG Monitors Market

The wearable medical devices market consists of sales of wearable medical equipment and related services that includes diagnostic devices and therapeutic devices like vital signs, sleep and neuro monitoring devices, electrocardiographs, pain management, respiratory therapeutic devices among others. The companies involved in wearable medical devices market design, manufacture and market medical wearables like watches, wristbands, clothing, ear wear and other devices for the applications like Remote Patient Monitoring, Ear wear, Home healthcare, Sports and Fitness which are designed for patient management and life-style disease management like prevention of diseases and maintenance of health with advantages such as weight control and physical activity monitoring.

Electrophysiology devices and equipment are used in the diagnosis and treatment of heart rhythm disorders through electrical activity. The main product types in the electrophysiology devices and equipment are electrophysiology ablation catheters, electrophysiology diagnostic catheters, and electrophysiology lab systems. Electrophysiology ablation catheters measure the electrical activity of the heart and diagnose abnormal heart rhythm. The various monitoring devices involved are electrocardiograph (ECG), electroencephalograph (EEG), electrocorticography (ECoG), electromyography (EMG), electroretinographic (ERG), electrooculography (EOG), Holter monitoring devices, X-ray systems, imaging and 3D mapping systems, and diagnostic electrophysiology catheters that are used in indication analysis of atrioventricular nodal reentry tachycardia (AVERT), Wolff-Parkinson-white syndrome (WPW), atrial flutter, and atrial fibrillation. The various end-users of electrophysiology devices and equipment are used in hospitals, diagnostic centres, and clinics. The electrophysiology devices and equipment market research report is one of a series of new reports from The Business Research Company that provides electrophysiology devices and equipment market statistics, including electrophysiology devices and equipment industry global market size, regional shares, competitors with a electrophysiology devices and equipment market share, detailed electrophysiology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the electrophysiology devices and equipment industry. This electrophysiology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global electrophysiology devices and equipment market size will grow from $5.43 billion in 2022 to $5.94 billion in 2023 at a compound annual growth rate (CAGR) of 9.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The electrophysiology devices and equipment market size is expected to grow to $8.07 billion in 2027 at a CAGR of 7.9%. An increase in the prevalence rate of cardiovascular diseases (CVD) forms one of the major drivers for the industries operating in the electrophysiology devices and equipment market. CVD cases remain the leading cause of death across the globe, which increases the demand for a quick and effective treatment of the disease, thus increasing the demand for electrophysiology devices. According to the Centers for Disease Control and Prevention (CDC), in 2020, 697,000 people died from heart diseases which was almost 1 in every 5 deaths. By 2030, 12.1 million people in the United States will suffer from atrial fibrillation, which is the most common type of heart arrhythmia. Lack of uniformity in the regulations governing the electrophysiology devices and equipment industry sometimes restricts the companies in the market from expanding globally, thereby hampering the market’s growth. The impact of individual country regulatory requirements can have huge implications for the availability of new electrophysiology devices and equipment. According to regulations in a few geographies, the manufacturers are required to conduct clinical trials (premarket and/or post-market) be either in whole or in part within a country. However, in markets such as Brazil, Japan, India, and China where local regulations are still in the nascent stage, the cost to run the trials is incurred by the manufacturers. For example, trials for devices like cardiac rhythm management (CRM) in multiple countries have less merit and do not reflect the true test results as it becomes difficult for the manufacturers to provide sufficient devices to run tests. To increase the profit margins and sales, the companies operating in the Electrophysiology (EP) devices and equipment industry are coming up with new technologies aimed towards improving EP mapping and localization technology. EP mapping is a procedure used to diagnose the origins of abnormal heart rhythms. This procedure uses an electrically sensitive catheter. With improved mapping technologies it becomes easy to detect and locate abnormalities in the heart. For example, in June 2020, Boston Scientific launched its DIRECTSENSE™ technology for monitoring the effect of radiofrequency energy delivery during the cardiac ablation procedure. The Reuse of a single-use device (SUD) is permitted by The Medicines and Healthcare products Regulatory Agency (MHRA) may impact the electrophysiology devices and equipment market growth as few of the products within the market may be reused. The MHRA allows the reuse of electrophysiology catheters, however, the device should be adherent to the medical devices directive and should have a CE mark. The reuse or reprocessing of electrophysiology catheters by electrophysiology (EP) laboratories in the US help in reducing the costs of these devices and lessening the environmental burden of the discarded bio-waste materials. As there is no clear regulation on reuse in developing nations such as Africa., Asia, Eastern Europe, Central America, and South America, the electrophysiology devices and equipment market may face a few challenges. In September 2021, Boston Scientific, a company operating in electrophysiology devices and equipment acquired Lumenis for a deal amount of $1.07 billion. With this acquisition, Boston scientific company expands its portfolio in the US and Japan. Lumenis is a medical equipment company and a technology company based in Israel. Major players in the electrophysiology devices and equipment market are St. Jude Medical, Boston Scientific Corporation, Abbott Laboratories, GE Healthcare, Philips Healthcare, Biotronik SE & Co. KG, Medtronic Inc., Biosense Webster, Microport Scientific Corporation, and Japan Lifeline Co. North America was the largest region in global electrophysiology devices and equipment market in 2022. Western Europe was the second-largest region in global electrophysiology devices and equipment market.The regions covered in the electrophysiology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the electrophysiology devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The electrophysiology devices and equipment market consist of sales of ablation catheters, diagnostic catheters, mapping system, accessories, and other electrophysiology devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global electrophysiology devices and equipment market is segmented - 1) By Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Lab Systems 2) By Monitoring Device Type: Electrocardiograph (ECG), Electroencephalograph (EEG), Electrocorticograph (ECoG), Electromyograph (EMG), Electroretinograph (ERG), Electrooculograph (EOG), Holter Monitoring Devices, X-Ray Systems, Imaging and 3D Mapping Systems, Diagnostic Electrophysiology Catheters 3) By Indication Analysis: Atrioventricular Nodal Reentry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), Atrial Flutter, Atrial Fibrillation 4) By End-Users: Hospitals, Diagnostic centers, Clinics

Cardiovascular monitoring and diagnostic devices and equipment are used for the diagnosis, monitoring, and treatment of cardiovascular diseases. The main product types of cardiovascular monitoring and diagnostic devices and equipment are cardiopulmonary stress testing systems, ECG data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and Holter monitoring systems. ECG monitoring equipment is an electronic device that is used to record the electrical activity of the heart. The various types involved are heart disease and coronary heart disease. The various end-users involved are hospitals/physician clinics (continuous glucose monitors), home/emergency, and research and development (clinical trials, universities, CRO). The cardiovascular monitoring and diagnostic devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cardiovascular monitoring and diagnostic devices and equipment market statistics, including cardiovascular monitoring and diagnostic devices and equipment industry global market size, regional shares, competitors with a cardiovascular monitoring and diagnostic devices and equipment market share, detailed cardiovascular monitoring and diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular monitoring and diagnostic devices and equipment industry. This cardiovascular monitoring and diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global cardiovascular monitoring and diagnostic devices and equipment market size will grow from $3.12 billion in 2022 to $3.36 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cardiovascular monitoring and diagnostic devices and equipment market size is expected to grow to $4.31 billion in 2027 at a CAGR of 6.4%. The cardiovascular monitoring and diagnostic devices and equipment market is being driven by an increasing number of people suffering from obesity and diabetes. Risk factors including high blood pressure and high cholesterol are associated with obesity and diabetes leads to cardiovascular diseases. For instance, as per a study conducted by the American Heart Association (AMA), by 2030, 22.2 million CVD is expected to grow. According to another study conducted by AMA in the U.S., 26 million people have been diagnosed with diabetes, and above 9 million further, have the condition but it hasn't yet been diagnosed. The cardiovascular monitoring and diagnostic devices and equipment market is being restrained by the FDA's regulatory control over these devices based on the risks associated with this equipment. Cardiovascular monitoring and diagnostic devices fall into the class II category as per the FDA, which includes devices with moderate to high risk associated with usage. The Class II devices are specially controlled with performance standards which provide the manufacturers with performance specifications, postmarket surveillance which monitors the safety of the device after being released in the market, and also other standards like patient registries and special labeling requirements. For instance, Angel medical systems’ implantable cardiac monitor was unanimously rejected by a panel of FDA experts due to unmet performance specifications. ICMs continuously monitor the electrocardiogram (ECG) of the patient to conduct a real-time examination of the heart rhythm, for up to 36 months. ICMs are mostly used in the analysis of transitory symptoms which have an arrhythmic origin, such as unexplained palpitations. For example, in July 2020, Medtronic received U.S. Food and Drug Administration (FDA) clearance and European CE label approval for its Linq II insertable cardiac monitor (ICM) by remote programming, allowing clinicians to optimize device settings without the requirement for patients to return to the hospital. The launch of new products is a key trend gaining popularity in the cardiovascular monitoring and diagnostic devices and equipment market. Companies in the market are focusing on the launch of new products to improve their product portfolio and strengthen their market position. For example, in August 2022, SmartCardia SA, a medical equipment manufacturer in Switzerland, launched 7L patch, its 7-lead cardiac monitoring patch in India. This patch monitor combines medical wearable technology with artificial intelligence (AI) to provide predictive and personalized patient insights through remote monitoring. The 7L patch is tracked by SmartCardia’s AI platform is interpreted by cardiologists and certified cardiac technicians and performs real-time detection of important arrhythmia events at cardiologist level accuracy. The US FDA has classified cardiovascular monitoring and diagnostic devices into the Class II category, as they have a moderate to high risk associated with usage. Class II devices are bounded by device-specific regulations which include performance standards, premarket data requirements, postmarket surveillance, and labeling requirements associated with device usage. For instance, the labeling should consist of contraindications, adverse reactions, precautions, warnings, and other instructions before the device is released into the market. Major players in the cardiovascular monitoring and diagnostic devices and equipment market are Medtronic PLC., Boston Scientific Corporation, GE Healthcare, Johnson & Johnson, Philips Healthcare, Siemens Healthcare, St. Jude MedicalInc., Nihon Kohden Corporation, FUKUDA DENSHI Co. Ltd., and Sorin Group. North America was the largest region in global cardiovascular monitoring and diagnostic devices and equipment market in 2022. Western Europe was the second-largest region incardiovascular monitoring and diagnostic devices and equipment market. The regions covered in global cardiovascular monitoring and diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cardiovascular monitoring and diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The cardiovascular monitoring and diagnostic devices and equipment market consist of sales of cardiopulmonary stress testing systems, ECG data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and holter monitoring systems that are used for diagnosis and treatment of cardio diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global cardiovascular monitoring and diagnostic devices and equipment market is segmented - 1) By Product Type: Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems, Holter Monitoring Systems 2) By End-Use: Hospitals/Physician Clinic (Continuous Glucose Monitors), Home/Emergency, Research and Development (Clinical Trials, Universities, CRO) 3) By Type: Heart Disease, Coronary Heart Disease

mHealth apps are wearable devices and health tracking apps used to monitor and share health information by using mobile technology. mHealth apps include clinical and diagnostic apps, remote monitoring apps, healthy-living apps, clinical reference apps, and productivity apps. These apps are used to monitor and collect community data and clinical data by healthcare providers. The main types of mHealth apps include disease and treatment management, wellness management, and others. The disease and treatment management apps are used to treat the diseases easily through a smartphone and provide primary care from home by using some apps such as mobile MIM radiology app. The wellness management apps are used to provide patient wellness information through mHealth apps. These are divided into connected medical devices which include heart rate meters, wearable fitness sensor devices, blood pressure monitors, pulse oximeters, and others that are used to check body temperatures and insulin levels. mHealth apps are used in various applications such as monitoring services, fitness solutions, diagnostic services, treatment services, and others such as medication tracking, diet, and nutrition. mHealth apps are generally used by physicians, patients, insurance companies, research centers, pharmacies, biopharmaceutical companies, government, tech companies, and others such as telemedicine apps, and administration apps. The mHealth apps market research report is one of a series of new reports from The Business Research Company that provides mHealth apps market statistics, including mhealth apps industry global market size, regional shares, competitors with a mHealth apps market share, detailed mhealth apps market segments, market trends and opportunities, and any further data you may need to thrive in the mHealth apps industry. This mHealth apps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global mhealth apps market size grew from $45.31 billion in 2022 to $56.77 billion in 2023 at a compound annual growth rate (CAGR) of 25.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The mhealth apps market size is expected to grow to $136.64 billion in 2027 at a CAGR of 24.6%. Increasing publicity of mHealth applications due to their increasing benefits to improving patient disease state is expected to propel the growth of the mHealth apps market. Many people are increasingly adapting to the usage of health apps and therefore their popularity is increasing. These apps provide many benefits to monitoring patient disease state. According to Healthcare Information and Management Systems Society, a health app is regularly used by nearly 64% of adults in the United States to measure health metrics. Further, a new study by BMJ in 2021 reported that the Google Play store has nearly 2% of mHealth apps. mHealth apps are being used to improve the treatment and provide information that is easily accessible. Health care professionals are using these health applications for educating the patient and also for self-monitoring. Therefore, the increasing publicity of mHealth applications due to their increasing benefits to improve patient care is driving the growth of the mHealth app market. The adoption of artificial intelligence (AI) and 5G are shaping the mHealth apps market. Artificial intelligence is human intelligence that is processed by machines such as computers and focuses on learning, reasoning, and self-correction and AI is adopting 5G to improve customer experiences. The advancement in artificial intelligence (AI) and 5G has been introducing new opportunities for service providers. Artificial intelligence plays a major role to improve customer service and creating new challenges and even solves network complexities. Companies are launching AI platforms to enhance customer experiences. For example, in January 2020, Babylon Health, a UK-based digital health service provider announced that they are developing an AI-integrated health application to serve 300,000 people in England. In February 2021, Philips, a Netherlands-based health technology company offering mHealth apps based acquired BioTelemetry Inc. for an undisclosed amount. With this acquisition, Philips aims to transform the health continuum along with the delivery of care with integrated solutions. The acquisition will offer the patient care management portfolio with cardiac diagnostics and monitoring. Biotelemetry Inc is a health technology company engaged in offering mHealth apps. Major players in the mHealth apps market are Omron Healthcare Inc., Johnson and Johnson, BioTelemetry Inc., Bristol-Myers Squibb Company, Qualcomm Technologies Inc., Diversinet Corp., Medtronic MiniMed, Agamatrix Inc., Apple Inc., Pfizer Inc., GlaxoSmithKline plc, Merck and Co. Inc., Novartis AG, Abbott Laboratories, AstraZeneca PLC., Sanofi, Ovia Health, Livongo Health, Orange, Sony, F. Hoffmann-La Roche Ltd., Allscripts, Jawbone Health Hub Inc., Boston Scientific Corporation, Withings S.A., iHealth Labs Inc., Nutrimedy, and Dr. Pad. North America was the largest region in the mHealth apps market in 2022. Asia-Pacific is expected to be the fastest-growing region in mHealth apps market. The regions covered in mHealth apps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the mHealth apps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The mHealth apps market includes revenues earned by entities by clinical and diagnostic apps, remote monitoring apps, productivity apps, reminder apps, text and video communication apps, prescription apps, and mental health apps. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global mhealth apps market is segmented - 1) By App Type: Disease And Treatment Management, Wellness Management, Other App Types 2) By Connected Medical Devices: Heart Rate Meters, Wearable Fitness Sensor Device, Blood Pressure Monitors, Pulse Oximeters, Other Connected Medical Devices 3) By Application: Monitoring Services, Fitness Solutions, Diagnostic Services, Treatment Services, Other Applications 4) By End-User: Physicians, Patients, Insurance Companies, Research Centers, Pharmacy, Biopharmaceutical Companies, Government, Tech Companies, Other End-Users

Diabetes Care Devices Market Definition

The diabetes care devices (or) equipment market consists of sales of diabetes care devices and related services by entities (organizations, sole traders and partnerships) that produce diabetes care devices used to monitor and control blood glucose levels in diabetic patients. This industry includes establishments that produce blood glucose test strips, continuous glucose monitoring devices, and blood glucose meters used to check blood glucose levels; insulin pens, syringes, pumps and injectors used to inject insulin; and others. Diabetes care devices are designed to diagnose, monitor or manage type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar.

Implantable infusion pumps are drug delivery systems implanted in the patients body that pump the medication into the blood stream in a controlled manner. The implantable infusion pumps market is segmented by type into patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and others. The insulin pump is a small device that is put beneath the skin during the operation to deliver insulin in diabetic patients. The various applications of implantable infusion pumps are oncology, pediatrics/neonatology, gastroenterology, hematology, diabetes, and others that are used by hospitals, ambulatory surgical centers, and specialty clinics. The implantable infusion pumps market research report is one of a series of new reports from The Business Research Company that provides implantable infusion pumps market statistics, including implantable infusion pumps industry global market size, regional shares, competitors with a implantable infusion pumps market share, detailed implantable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the implantable infusion pumps industry. This implantable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global implantable infusion pumps market grew from $18.26 billion in 2022 to $19.14 billion in 2023 at a compound annual growth rate (CAGR) of 4.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The implantable infusion pumps market is expected to grow from $23.12 billion in 2027 at a CAGR of 4.8%. The increased prevalence of people with chronic pain, cancer, and diabetes is expected to drive the demand for implantable infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, as the aging population and shifts in social behavior lead to a gradual increase in these diseases. In diseases such as chronic arachnoiditis, which is a condition where one of the membranes surrounding the spinal cord swells, implantable infusion pumps deliver lower dosages of drugs and tend to provide more efficient pain relief. The prevalence of chronic diseases is expected to increase by 57% by 2020, according to the World Health Organization. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the implantable infusion pumps market. The safety concern regarding implantable infusion pumps is a key factor hampering the growth of the implantable infusion pumps market. The magnetic resonance (MR) system can be useful in the diagnosis of a wide range of conditions and diseases, but the MRI setting poses a risk factor for patients with implantable infusion pumps. An MRI examination can influence the programming or functionality of an infusion pump, even if specific requirements have been met. The US food and drug administration received evidence of significant adverse effects including harm to the patient and death associated with the use of implantable infusion pumps in the MR field. Therefore, the safety concerns regarding implantable infusion pumps are expected to limit the growth of the implantable infusion pumps market. Companies in the implantable infusion pump market are increasingly focusing on developing smart infusion pumps. The use of wireless technology in health monitoring devices is increasing, which enhances the ease of usage, connectivity, and data analysis. The integration of wireless technology allows the transfer of data from the device to a smartphone or a wireless device through Bluetooth or cellular connection for data processing and then to display the results, which can be used for further study and to check the health condition of the individual. Software platforms are being developed that allow patient monitoring and reduce human error. In September 2021, Medtronic, a US-based medical device company, acquired implanted infusion pump technology from Alfred E. Mann Foundation. The acquisition is aimed to improve insulin delivery in people with type-1 diabetes. Alfred E. Mann Foundation is a US-based scientific research foundation developing implantable infusion pumps and other medical devices. Major players in the implantable infusion pumps market are Medtronic, Boston Scientific Corporation, Nevro Corporation, Cyberonics, Baxter, B=. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical, Terumo Corporation, and Neuropace. North America was the largest region in the implantable infusion pumps market in 2022. Asia-Pacific was the second-largest region in the global implantable infusion pumps market. The regions covered in the global implantable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the implantable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The implantable infusion pumps market consists of sales of instruments such as patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global implantable infusion pumps market is segmented - 1) By Type: Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Other Types 2) By Applications: Oncology, Pediatrics/Neonatology, Gastroenterology, Hematology, Diabetes, Other Applications 3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

A peristaltic pump also known as a roller pump is a positive displacement pump that moves the fluid at a constant speed regardless of the pressure at the inlet end and can be used to pump a wide range of fluids. The fluid is stored within a flexible hose or tube fitted inside the pump casing. The main types of peristaltic pumps include peristaltic tube pumps and peristaltic hose pumps. Low-pressure pumps, also known as peristaltic tube pumps, have dry casings and non-reinforced casings and use rollers to provide compressive power. The different types of products include fixed speed pumps and variable speed pumps, and the discharge capacity ranges up to 30 pounds per square inch (psi), 30-50 psi, 50-100 psi, 100-200 psi, and above 200 psi. It is implemented in various verticals such as pharmaceutical and medical, water and wastewater treatment, food and beverage, chemical processing, mining, pulp and paper and others. The peristaltic pumps market research report is one of a series of new reports from The Business Research Company that provides peristaltic pumps market statistics, including peristaltic pumps industry global market size, regional shares, competitors with a peristaltic pumps market share, detailed peristaltic pumps market segments, market trends and opportunities, and any further data you may need to thrive in the peristaltic pumps industry. This peristaltic pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global peristaltic pumps market size grew from $1.51 billion in 2022 to $1.67 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The peristaltic pumps market size is expected to grow to $2.48 billion in 2027 at a CAGR of 10.4%. The increasing need for wastewater treatment is expected to fuel the growth of the peristaltic pumps market in the forecast period. Wastewater treatment is the method of removing pollutants from wastewater or sewage and converting it to an effluent that can be added to the water supply with minimal environmental effects. Peristaltic pumps are the preferred pump for dosing sodium hypochlorite due to their highly accurate metered flow, which is used in wastewater treatment to destroy bacteria. Therefore, the increasing need for wastewater treatment propels the growth of the peristaltic pumps market. Technological advancements are shaping the peristaltic pumps market. Peristaltic pump manufacturing companies are focusing on developing innovative technical solutions for peristaltic pumps with increased accuracy and the ability to pump fluids at low pressures. For instance, in January 2020, a US-based Cole-Parmer Instrument Company, LLC launched Reglo Peristaltic Pump Series, built to be highly accurate low-flow (100 mL/min) models with MasterflexLive technology and compliant with 21 CFR Part 11 and EU Annex 11 regulations. The combination of features intends to provide a fluid handling experience that is connected, responsive, strong, and stable. In March 2016, Watson-Marlow Fluid Technology Group, a UK-based manufacturer of positive displacement pumps, launched 530 series peristaltic pumps for upstream and downstream bioprocessing tasks with high precession and accuracy. In September 2020, Ingersoll Rand, a US-based industrial manufacturing company, acquired Albin Pump for an undisclosed amount. This acquisition is expected to expand the technical capabilities of Ingersoll Rand in peristaltic pumps and accelerate the company's expansion into electrically powered positive displacement pumps. Albin Pump is a France-based peristaltic pump manufacturing company. Major players in the peristaltic pumps market are Watson-Marlow Fluid Technology Group, Verder Group, Cole-Parmer Instrument Company LLC, ProMinent Group, Graco Inc., Randolph Austin, IDEX Corporation, Wanner Engineering, Heidolph Instruments, Gilson Inc., Ravel Hiteks Pvt. Ltd., Albin Pumps, and WELCO Co. Ltd. Asia-Pacific was the largest region in the peristaltic pumps market in 2022. The regions covered in the peristaltic pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the peristaltic pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The peristaltic pumps market consists of sales of peristaltic hose pumps and peristaltic tube pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global peristaltic pumps market is segmented - 1) By Type: Peristaltic Tube Pumps, Peristaltic Hose Pumps 2) By Product Type: Fixed Speed Pumps, Variable Speed Pumps 3) By Discharge Capacity: Up to 30 psi, 30-50 psi, 50-100 psi, 100-200 psi, Above 200 psi 4) By End-User: Pharmaceutical And Medical, Water And Wastewater Treatment, Food And Beverage, Chemical Processing, Mining, Pulp And Paper, Other End-Users

Vital parameter monitoring devices and equipment are used to monitor critical parameters such as blood pressure, heart rate, and other physiological parameters. The main product types of vital parameter monitoring devices and equipment are blood pressure monitoring devices, pulse oximeters, and temperature monitoring devices. Blood pressure monitoring devices are electronic devices that are used to monitor blood pressure. The blood pressure monitoring devices are aneroid BP monitors, digital BP monitors, ambulatory BP monitors, and blood pressure instrument accessories. The pulse oximeters are table-top/bedside pulse oximeters, fingertip pulse oximeters, hand-held pulse oximeters, wrist-worn pulse oximeters, and pediatric pulse oximeters. The temperature monitoring devices are digital thermometers, infrared thermometers, and temperature strips. The various end-users are hospitals, clinics, ambulatory surgery centres, and home care settings. The vital parameter monitoring devices and equipment market research report is one of a series of new reports from The Business Research Company that provides vital parameter monitoring devices and equipment market statistics, including vital parameter monitoring devices and equipment industry global market size, regional shares, competitors with a vital parameter monitoring devices and equipment market share, detailed vital parameter monitoring devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the vital parameter monitoring devices and equipment industry. This vital parameter monitoring devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global vital parameter monitoring devices and equipment market size will grow from $6.62 billion in 2022 to $7.13 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The vital parameter monitoring devices and equipment market size is expected to grow to $9.14 billion in 2027 at a CAGR of 6.4%. An increase in the geriatric population globally is driving the vital parameter monitoring devices and equipment market. Old people are more prone to medical conditions and diseases and require monitoring of vital health parameters. According to the World Health Organization, in 2020, there were about 1 billion people aged 65 years or above and the number is expected to reach 1.4 billion by 2030 and 2.1 billion by 2050.. The increasing number of old age patients seeking treatments and surgeries is contributing to market growth. The security concerns related to wireless vital parameter monitoring devices are acting as a restraint on the vital parameter monitoring devices and equipment market. Medical devices with features like wireless connectivity, remote monitoring, and near-field communication allow health professionals to monitor vital parameters like electrocardiogram (ECG), blood pressure (BP), and temperature from anywhere with convenience. These devices are connected to a broad network via IoT, making them potential entry points to larger hospital networks. This connectivity could be used by hackers to mount a ransomware attack against a large hospital and can hold the vital systems of the hospital hostage, or breach sensitive medical records. The medical data obtained in these types of attacks can be used for malicious activities like tax fraud or identity theft, and can even be used to track active drug prescriptions. According to Linchpinseo data 2022, Nearly 4 million connected devices monitor every part of the human body. Vital parameter monitoring devices and equipment companies are increasingly investing in the research and development of wearable health devices (WHDs). WHDs are smart electronic devices that can be worn by a consumer and are capable of tracking information related to health and fitness. These devices facilitate better monitoring of health and can help in early diagnosis and guidance from doctors. For instance, the ViSi Mobile developed by Sotera Wireless is a wearable device that can provide many vital parameters such as heart rate, respiration rate, oxygen saturation, pulse rate, etc. VitalTag is another wearable device developed as part of the Department of Homeland Security Science and Technology Directorate program to detect and monitor heart rate, blood oxygen levels, body temperature, and blood pressure. Current Health recently got FDA approval for an artificial intelligence-powered wearable device that monitors patient vital signs at the hospital and home. Vital parameter monitoring devices and equipment manufacturers are governed by the various quality and safety regulations. For instance, in the USA, the Food and Drug Administration's 510 (k) regulation for safety and effectiveness of vital parameter monitoring devices and equipment states that the device should be tested non-clinically for electrical safety, electromagnetic compatibility. Vital parameter monitoring devices and equipment are classified as class II under title 21, parts 800 to 898 by FDA. Class II devices are medical devices having a moderate risk. Major players in the vital parameter monitoring devices and equipment market are Welch Allyn (Hill-Rom Holdings), SunTech Medical (Halma plc), Masimo Corporation, General Electric Company, Medtronic PLC., Nihon Kohden Corporation, Koninklijke Philips N.V, A&D Company, Contec Medical Systems Co., and Nonin Medical. Asia-Pacific was the largest region in the global vital parameter monitoring devices and equipment market in 2022. North America was the second-largest region in the v tal parameter monitoring devices and equipment market. The regions covered in the global vital parameter monitoring devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the vital parameter monitoring devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The vital parameter monitoring devices and equipment market consist of sales of instruments such as blood pressure monitoring devices, pulse oximeters, and temperature monitoring devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global vital parameter monitoring devices and equipment market is segmented - 1) By Product Type: Blood Pressure Monitoring Devices, Pulse Oximeters, Temperature Monitoring Devices 2) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings 3) By Blood Pressure Monitoring Devices: Aneroid BP Monitors, Digital BP Monitors, Ambulatory BP Monitors, Blood Pressure Instrument Accessories 4) By Pulse Oximeters: Table-top/Bedside Pulse Oximeters, Fingertip Pulse Oximeters, Hand-held Pulse Oximeters, Wrist-worn Pulse Oximeters, Pediatric Pulse Oximeters 5) By Temperature Monitoring Devices: Digital Thermometers, Infrared Thermometers, Temperature Strips